ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Health Technology

Nipro Corp.

  • 1,431.00 JPY
  • -24.00
  • -1.65%
  • Japan
    Oct 19, 2018
  • Ticker
  • Prev. close
  • Market cap (JPY)
  • Market cap (USD)
  • Shares

Business Summary

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2018 JPYUSD
Gross Profit128,791M1,162.03M
Operating income26,997M243.58M
Income before tax17,026M153.61M
Net income11,830M106.73M
Diluted EPS64.510.58
Dividends Per Share28.500.25
Total Assets828,658M7,791.79M
Total liabilities645,169M6,066.46M
Total equity172,622M1,623.14M
Operating cash flow41,046M370.34M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 300,752M 325,084M 366,650M 359,699M 395,397M
Gross Profit 87,532M 99,559M 115,877M 115,097M 128,791M
Operating income 12,289M 16,571M 25,083M 28,801M 26,997M
Income before tax 12,891M 19,908M 26,284M 18,324M 17,026M
Net income 2,861M 12,470M 19,718M 11,346M 11,830M
EBITDA 62,364M 49,632M 58,918M 62,836M 62,993M
Diluted EPS 16.29 80.95 114.67 61.33 64.51
Dividends Per Share 30.50 32.50 33.50 29 28.50
Total Assets 621,221M 698,577M 710,681M 754,748M 828,658M
Total liabilities 485,261M 519,767M 535,174M 578,335M 645,169M
Total equity 125,427M 167,660M 165,998M 166,083M 172,622M
Operating cash flow 21,552M 27,981M 29,934M 33,472M 41,046M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 3,002.37M 2,959.16M 3,053.27M 3,321.70M 3,567.52M
Gross Profit 873.82M 906.26M 964.96M 1,062.88M 1,162.03M
Operating income 122.67M 150.84M 208.87M 265.96M 243.58M
Income before tax 128.68M 181.21M 218.87M 169.21M 153.61M
Net income 28.56M 113.51M 164.20M 104.77M 106.73M
EBITDA 622.57M 451.78M 490.63M 580.27M 568.36M
Diluted EPS 0.16 0.73 0.95 0.56 0.58
Dividends Per Share 0.30 0.29 0.27 0.26 0.25
Total Assets 6,032.15M 5,825.11M 6,323.06M 6,773.29M 7,791.79M
Total liabilities 4,711.95M 4,334.10M 4,761.54M 5,190.11M 6,066.46M
Total equity 1,217.91M 1,398.04M 1,476.91M 1,490.46M 1,623.14M
Operating cash flow 215.15M 254.70M 249.27M 309.10M 370.34M

Valuation Measures

Mar 2018
Operating margin6.82%
Profit margin2.99%

Key executives

  • President & Representative Director: Yoshihiko Sano
  • Director & Manager-Administration: Masanobu Iwasa
  • Director & Deputy Manager-Production Business: Hideo Okamoto
  • Director: Itsuo Akasaki
  • Director & Manager-Production Technology Center: Kazuhiko Sano


  • Nippon Electric Glass Co., Ltd. (12.7%)
  • Nipro Corp. (4.0%)
  • Asset Management One Co., Ltd. (2.6%)
  • Resona Holdings, Inc. (2.5%)
  • Nomura Asset Management Co., Ltd. (2.0%)
  • The Vanguard Group, Inc. (1.6%)
  • Norges Bank Investment Management (1.5%)
  • Dimensional Fund Advisors LP (1.1%)
  • JAPAN POST INSURANCE Co., Ltd. (1.1%)
  • SANO KAZUMI (1.1%)

Contact Details

  • Website:
  • Address: 3-9-3 Honjo-Nishi, Kita-Ku, Osaka, 531-8510, Japan
  • Phone: +81.6.6372.2331

Related Companies

  • Nipro ES Pharma KK
  • Nipro Medical OOO
  • Anyang Nipro Changda Pharmaceutical Packaging Co. Ltd.
  • OOO Ural Glass Plant
  • Nipro Nordics AB
  • Nipro India Corp. Pvt Ltd.
  • Nipro Medical (India) Pvt Ltd.
  • Nipro JMI Co. Ltd.
  • Nipro Poland Sp zoo
  • Nipro Glass Germany AG
  • Nipro Middle East Free Zone Establishment
  • Nipro Malaysia Sdn. Bhd.
  • Nipro France SA
  • Jilin Nipro Jiaheng Pharmaceutical Packaging Co. Ltd.
  • Nipro Medical Corporation Produtos Medicos Ltda.
  • Nipro Sales (Thailand) Co. Ltd.
  • Nipro Medical of Puerto Rico, Inc.
  • Nipro Trading (Shanghai) Co. Ltd.
  • Nipro South Africa Pty Ltd.
  • Nipro Asia Pte Ltd.
  • PT Nipro Indonesia Jaya
  • Nipro Medical (Hefei) Co. Ltd.
  • Nipro Glass Americas Corp.
  • Nipro Glass India Pvt Ltd.
  • Nipro Senegal SUARL
  • Nipro Pharma Glass AG
  • Unitika Ltd. /Medical Products Business/
  • Nipro (Shanghai) Co. Ltd.
  • Cell Science & Technology Institute, Inc.
  • Nipro Employee Incentive Plan


  • NxStage Medical, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Bioteque Corporation
  • Gerresheimer AG
  • Nephros, Inc.
Last Updated on 19 Oct, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media